Jane Street
CLVS

Jane Street’s Clovis Oncology, Inc. CLVS Stock Holding History

Jane Street’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-52,609
Closed -$63K – 10646
2022
Q3 		$63K Sell
52,609
-47,081
-47% -$73.4K ﹤0.01% 8846
2022
Q2 		$180K Sell
99,690
-294,220
-75% -$434K ﹤0.01% 8273
2022
Q1 		$796K Buy
393,910
+197,933
+101% +$389K ﹤0.01% 6596
2021
Q4 		$531K Sell
195,977
-30,851
-14% -$114K ﹤0.01% 7148
2021
Q3 		$1.01M Sell
226,828
-131,343
-37% -$633K ﹤0.01% 5883
2021
Q2 		$2.08M Buy
358,171
+253,540
+242% +$1.49M ﹤0.01% 4269
2021
Q1 		$735K Sell
104,631
-72,047
-41% -$483K ﹤0.01% 6066
2020
Q4 		$849K Buy
176,678
+87,722
+99% +$444K ﹤0.01% 4933
2020
Q3 		$519K Buy
+88,956
New +$532K ﹤0.01% 5093
2020
Q2 		– Sell
-43,887
Closed -$332K – 7725
2020
Q1 		$279K Sell
43,887
-212,235
-83% -$1.7M ﹤0.01% 4293
2019
Q4 		$2.67M Buy
256,122
+243,968
+2,007% +$1.77M ﹤0.01% 1628
2019
Q3 		$47K Sell
12,154
-27,932
-70% -$226K ﹤0.01% 4895
2019
Q2 		$596K Sell
40,086
-3,953
-9% -$71.4K ﹤0.01% 3349
2019
Q1 		$1.09M Sell
44,039
-24,170
-35% -$606K ﹤0.01% 2699
2018
Q4 		$1.23M Buy
68,209
+44,814
+192% +$916K ﹤0.01% 2292
2018
Q3 		$687K Buy
23,395
+5,317
+29% +$206K ﹤0.01% 3229
2018
Q2 		$822K Buy
18,078
+7,893
+77% +$384K ﹤0.01% 2994
2018
Q1 		$538K Sell
10,185
-10,916
-52% -$637K ﹤0.01% 3407
2017
Q4 		$1.44M Sell
21,101
-51,787
-71% -$3.62M ﹤0.01% 1919
2017
Q3 		$6.01M Buy
72,888
+10,634
+17% +$843K 0.02% 778
2017
Q2 		$5.83M Buy
62,254
+44,560
+252% +$2.73M 0.02% 688
2017
Q1 		$1.13M Buy
+17,694
New +$1.08M 0.01% 1937
2016
Q4 		– Sell
-45,606
Closed -$1.61M – 4776
2016
Q3 		$1.64M Buy
45,606
+25,844
+131% +$554K 0.01% 1399
2016
Q2 		$271K Buy
+19,762
New +$289K ﹤0.01% 3439
2016
Q1 		– Sell
-15,182
Closed -$321K – 4794
2015
Q4 		$531K Sell
15,182
-11,238
-43% -$725K ﹤0.01% 2415
2015
Q3 		$2.43M Buy
+26,420
New +$2.29M 0.02% 826
2015
Q2 		– Sell
-5,825
Closed -$499K – 4178
2015
Q1 		$432K Buy
+5,825
New +$411K ﹤0.01% 2190
2013
Q4 		– Sell
-20,275
Closed -$1.23M – 3030
2013
Q3 		$1.23M Buy
20,275
+10,984
+118% +$779K 0.01% 926
2013
Q2 		$622K Buy
+9,291
New +$418K 0.01% 1258

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Jane Street's CLVS Position: Q4 2022 in Review

Jane Street sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 52,609 shares — an estimated $63K sold.

Jane Street first reported a position in CLVS in Q2 2013 and held it in 29 quarters. The position peaked at $6.01M in Q3 2017. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Jane Street reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Jane Street sold 52,609 Clovis Oncology, Inc. shares in Q4 2022, an estimated $63K.
  • Jane Street first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 29 quarters.
  • Jane Street's Clovis Oncology, Inc. position peaked at $6.01M in Q3 2017.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Jane Street's 13F filing for Q4 2022, filed 15 Feb 2023.